Figures and Tables

From the following article:

The sweet and sour of cancer: glycans as novel therapeutic targets

Mark M. Fuster & Jeffrey D. Esko

Nature Reviews Cancer 5, 526-542 (July 2005)

doi:10.1038/nrc1649

Figure 1 - The sweet and sour of cancer: glycans as novel therapeutic targets

Figure 1

Important glycans involved in tumour progression.

Figure 2 - The sweet and sour of cancer: glycans as novel therapeutic targets

Figure 2

Stages of tumour progression.

Figure 3 - The sweet and sour of cancer: glycans as novel therapeutic targets

Figure 3

Glycans participate in major pathophysiological events during tumour progression.

Table 1 - The sweet and sour of cancer: glycans as novel therapeutic targets

Table 1

Examples of glycan families involved in tumour progression

Table 2 - The sweet and sour of cancer: glycans as novel therapeutic targets

Table 2

Potentiation of tumour growth by HSPGs and heparin-binding growth factors

Table 3 - The sweet and sour of cancer: glycans as novel therapeutic targets

Table 3

Current clinical targets of glycans in cancer